Leaders in Pharmaceutical Business Intelligence (LPBI) Group

LIVE – 11/18/2015 8:00 a.m. – Welcome & Opening Remarks: 11th Annual Personalized Medicine Conference, November 18-19, 2015, Harvard Medical School

Live Press Coverage in REAL TIME

Aviva Lev-Ari, PhD, RN

Director & Founder, Leaders in Pharmaceutical Business Intelligence, Boston

Co-Founder, GDE

8:00 a.m. – Welcome & Opening Remarks

Greetings

• Genomics
• digital and big data
• proteomics
• metabolomics

Just in 2000,  Genomics will revolutionize discoveries of causes for disease

• Cancer and Genomics

Innovations

• Sustaining Innovations
• Disctructive Innovations
• Distructive Technologies: Sequencing the Genome, 2015 = $1000 per Person
• Paradigm Shift

Personalized Medicine:

Disease Burden that develops over time vs Cost of reversibility of disease

Development of Disease

• Baseline risk
• earlier molecular detection
• clinical detection typical current intervention

2000 – 2015 Score Card of Personalized Medicine

Factors and Grades of Attainment

• technology (A+)
• predictive Diagnostic tools (B)
• Therapeutics (A-) – CANCER – the most advanced made
• Health Promotion (D)
• DIsease Prevention (D)
• Chronic Disease Mitigation (D)

Primary Care Personalized Health Planning Model

• Patient Responsibility
• Provider Responsibility
• Shared Responsibility

PRECISION TOOLS

• Clinical outcomes
• adversed event predictions

It is very difficult to develop Personalized Medicine — MUCH progres made in Ten years — Repost Card will be all A

– See more at: http://personalizedmedicine.partners.org/Education/Personalized-Medicine-Conference/Program.aspx#sthash.O4Znb9kq.dpuf

To Follow LIVE CONFERENCE COVERAGE PLEASE FOLLOW ON TWITTER USING

Meeting #: #PMConf

Meeting @: @HarvardPMConf

@PartnersPersMed

Overall good meeting #s:

#personalizedmedicine

#powerofgenomics

#genomics

#pharmanews

AND FOLLOW these @

@pharma_BI

@AVIVA_1950

@BiotechNews

TALK SPECIFIC # and @